Drug class review on beta adrenergic blockers final report
Beta blockers inhibit the chronotropic, inotropic, and vasoconstrictor responses to the catecholamines, epinephrine and norepinephrine by blocking beta receptors in the heart and vasculature. Beta blockers are used for various indications specific to each beta blocker and can include hypertension, c...
| Main Author: | |
|---|---|
| Corporate Authors: | , , |
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Portland, OR
Oregon Health & Science University
c2007, 2007
|
| Series: | Drug class reviews
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | Beta blockers inhibit the chronotropic, inotropic, and vasoconstrictor responses to the catecholamines, epinephrine and norepinephrine by blocking beta receptors in the heart and vasculature. Beta blockers are used for various indications specific to each beta blocker and can include hypertension, chronic stable angina, atrial arrhythmias, asymptomatic and symptomatic heart failure, migraine, and secondary prevention post-myocardial infarction. The purpose of this review is to compare the efficacy, effectiveness, and harms of beta blockers |
|---|---|
| Item Description: | Title from PDF title page (viewed June 8, 2011). - "September 2007." |
| Physical Description: | 1 online resource |